Counterpoint: The Potential Harms of Human Gene Editing Using CRISPR-Cas9

Françoise Baylis
  • Clinical Chemistry, February 2018, AACC
  • DOI: 10.1373/clinchem.2017.278317

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1373/clinchem.2017.278317

The following have contributed to this page: Francoise Baylis

In partnership with: